Table 2.
Prediction results for TPGLDA, KRWRH and LRLSLDA utilizing leave-one-out cross validation experiment on 15 diseases.
Disease name | No. of Associated lncRNAs | AUC | ||
---|---|---|---|---|
TPGLDA | KRWRH | LRLSLDA | ||
Gastric Cancer | 24 | 0.893 | 0.832 | 0.756 |
Colorectal Cancer | 21 | 0.884 | 0.782 | 0.687 |
Breast Cancer | 20 | 0.852 | 0.675 | 0.655 |
Hepatocellular Carcinoma | 20 | 0.911 | 0.891 | 0.751 |
Non-Small Cell | ||||
Lung Cancer | 15 | 0.799 | 0.759 | 0.765 |
Prostate Cancer | 13 | 0.886 | 0.807 | 0.758 |
Esophageal Squamous | ||||
Cell Carcinoma | 13 | 0.822 | 0.835 | 0.739 |
Ovarian Cancer | 12 | 0.892 | 0.731 | 0.768 |
Bladder Cancer | 11 | 0.883 | 0.774 | 0.765 |
Lung Cancer | 9 | 0.828 | 0.737 | 0.750 |
Melanoma | 9 | 0.939 | 0.627 | 0.815 |
Glioma | 9 | 0.820 | 0.710 | 0.808 |
Tumor | 8 | 0.950 | 0.786 | 0.625 |
Schizophrenia | 8 | 0.860 | 0.854 | 0.630 |
Papillary Thyroid Carcinoma | 7 | 0.892 | 0.700 | 0.835 |